Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Prucalopride in Critically Ill Patients With Paralytic Ileus
NCT04190173Phase 3Unknown
- Sponsor
- Prince of Songkla University
- Start
- Jul 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in paralytic ileus comparing Prucalopride with Placebo (2 arms). Primary endpoint: Change of maximum bowel diameter from baseline at 120 hours. Status: unknown.
02
Drugs
prucalopride
03
Conditions
paralytic ileus
Beyond the preview
Go deeper on NCT04190173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04190173.